These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31084461)

  • 1. Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review.
    Howard I
    J Palliat Med; 2019 Oct; 22(10):1227-1231. PubMed ID: 31084461
    [No Abstract]   [Full Text] [Related]  

  • 2. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States.
    Soriano-Co M; Batke M; Cappell MS
    Dig Dis Sci; 2010 Nov; 55(11):3113-9. PubMed ID: 20130993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong.
    Senderovich H; Waicus S
    Oncol Res Treat; 2022; 45(7-8):438-443. PubMed ID: 35504245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.
    Sorensen CJ; DeSanto K; Borgelt L; Phillips KT; Monte AA
    J Med Toxicol; 2017 Mar; 13(1):71-87. PubMed ID: 28000146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting.
    Price SL; Fisher C; Kumar R; Hilgerson A
    J Am Osteopath Assoc; 2011 Mar; 111(3):166-9. PubMed ID: 21464265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis in Palliative Care: A Systematic Review of Current Evidence.
    Doppen M; Kung S; Maijers I; John M; Dunphy H; Townsley H; Eathorne A; Semprini A; Braithwaite I
    J Pain Symptom Manage; 2022 Nov; 64(5):e260-e284. PubMed ID: 35705116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
    Khattar N; Routsolias JC
    Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area.
    Hernandez JM; Paty J; Price IM
    CJEM; 2018 Jul; 20(4):550-555. PubMed ID: 28835305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study.
    Pélissier F; Claudet I; Gandia-Mailly P; Benyamina A; Franchitto N
    J Emerg Med; 2016 Nov; 51(5):544-551. PubMed ID: 27485997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse].
    Naver AV; Theede K
    Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
    Desjardins N; Jamoulle O; Taddeo D; Stheneur C
    J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabinoid hyperemesis syndrome: A review of the literature].
    Desjardins N; Stheneur C
    Arch Pediatr; 2016 Jun; 23(6):619-23. PubMed ID: 27017363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclical hyperemesis secondary to cannabis abuse].
    Ochoa-Mangado E; Jiménez Giménez M; Salvador Vadillo E; Madoz-Gúrpide A
    Gastroenterol Hepatol; 2009; 32(6):406-9. PubMed ID: 19477551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
    Turgeman I; Bar-Sela G
    Expert Opin Investig Drugs; 2019 Mar; 28(3):285-296. PubMed ID: 30572744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cannabis hyperemesis syndrome].
    Bonnet U; Chang DI; Scherbaum N
    Fortschr Neurol Psychiatr; 2012 Feb; 80(2):98-101. PubMed ID: 21692016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.